Sotera Health (SHC) Stock Price, News & Analysis

Company Overview

Sotera Health Company is a global provider of sterilization, laboratory testing and advisory services for the medical device, pharmaceutical and food industries. Its services help customers assess product safety, meet regulatory requirements and prepare products for use.

Through Sterigenics, the company provides contract sterilization using technologies including ethylene oxide, gamma irradiation and electron beam processing. Nelson Labs offers microbiological and analytical testing, as well as consulting, for medical devices and pharmaceutical products. Nordion supplies Cobalt-60, which is used in certain sterilization processes, and medical isotopes.

Sotera Health serves customers in a range of international markets through facilities and operations across multiple regions. Its businesses support products distributed worldwide, including medical devices and pharmaceuticals that require sterilization or specialized testing.

Key Stats

• Today's Range: $16.15 to $16.65
• 50-Day Range: $15.87 to $19.33
• 52-Week Range: $13.09 to $19.85
• Volume: 2.65 million shs
• Average Volume: 2.66 million shs
• Market Capitalization: $4.74 billion
• P/E Ratio: 18.52
• Dividend Yield: N/A
• Price Target: $20.88
• Consensus Rating: Moderate Buy

Sotera Health Stock Analysis - MarketRank™

Sotera Health scored higher than 66% of companies evaluated by MarketBeat, and ranked 167th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Sotera Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 7 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

Sotera Health has a consensus price target of $21.14, representing about 27.3% upside from its current price of $16.61.

Amount of Analyst Coverage

Sotera Health has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 8.99%

Earnings Growth

Earnings for Sotera Health are expected to grow by 8.99% in the coming year, from $0.89 to $0.97 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sotera Health is 27.68, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.41.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sotera Health is 27.68, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.61.

Price to Book Value per Share Ratio

Sotera Health has a P/B Ratio of 6.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.80% of the float of Sotera Health has been sold short.

Short Interest Ratio / Days to Cover

Sotera Health has a short interest ratio ("days to cover") of 7.53.

Change versus previous month

Short interest in Sotera Health has recently increased by 2.15%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sotera Health does not currently pay a dividend.

Dividend Growth

Sotera Health does not have a long track record of dividend growth.

News and Social Media

• Score: 1.4 / 5
• News Sentiment: 0.22

News Sentiment

Sotera Health has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Sotera Health this week, compared to 3 articles on an average week.

Company Ownership

• Score: 2.0 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Sotera Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $21,173,528.00 in company stock.

Percentage Held by Insiders

15.36% of the stock of Sotera Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

91.03% of the stock of Sotera Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/03/2026
• Today: 11/13/2026
• Jefferies Global Healthcare Conference: 11/18/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:SHC
• CIK: 1822479
• Web: www.soterahealth.com
• Phone: 440-262-1410
• Fax: N/A
• Employees: 3,000
• Year Founded: 2017

Price Target and Rating

• Average Price Target for Sotera Health: $21.14
• High Price Target: $25.00
• Low Price Target: $15.00
• Potential Upside/Downside: +27.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.60
• Trailing P/E Ratio: 18.52
• Forward P/E Ratio: 17.12
• P/E Growth: N/A
• Net Income: $77.94 million
• Net Margins: 14.11%
• Pretax Margin: 22.35%
• Return on Equity: 38.46%
• Return on Assets: 7.66%

Debt

• Debt-to-Equity Ratio: 3.04
• Current Ratio: 3.13
• Quick Ratio: 2.91

Sales & Book Value

• Annual Sales: $1.16 billion
• Price / Sales: 4.08
• Cash Flow: $1.30 per share
• Price / Cash Flow: 12.76
• Book Value: $2.57 per share
• Price / Book: 6.46

Miscellaneous

• Outstanding Shares: 285,630,000
• Free Float: 241,758,000
• Market Cap: $4.74 billion
• Optionable: Optionable
• Beta: 1.94